Detalles de la búsqueda
1.
Circulating tumor DNA landscape and prognostic impact of acquired resistance to targeted therapies in cancer patients: a national center for precision medicine (PRISM) study.
Mol Cancer
; 22(1): 176, 2023 11 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37924050
2.
ProTarget: a Danish Nationwide Clinical Trial on Targeted Cancer Treatment based on genomic profiling - a national, phase 2, prospective, multi-drug, non-randomized, open-label basket trial.
BMC Cancer
; 23(1): 182, 2023 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36814246
3.
Extensive genomic analysis in patients with KRAS-mutated solid tumors shows high frequencies of concurrent alterations and potential targets but has limited clinical impact.
Acta Oncol
; 61(12): 1499-1506, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36529989
4.
New pathogenic germline variants identified in mesothelioma.
Lung Cancer
; 179: 107172, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36944283
5.
Persistent anti-tumor response in cancer patients experiencing pneumonitis related to immune checkpoint blockade.
Acta Clin Belg
; 76(2): 144-148, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31495282
6.
Letter re: Hyperprogressive disease during PD-1 blockade in patients with advanced gastric cancer.
Eur J Cancer
; 193: 113309, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37776631
7.
Blockade of the renin-angiotensin system in small arteries and anticontractile function of perivascular adipose tissue.
J Hypertens
; 33(5): 1039-45, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25909701
Resultados
1 -
7
de 7
1
Próxima >
>>